Expressing the sense of the House of Representatives that the United States should reduce and maintain the Federal unified budget deficit at or below 3 percent of gross domestic product.

HRES981 is an early-stage House resolution expressing the sense of Congress that the federal budget deficit should be reduced to 3% of GDP or less by the end of FY2030, with a goal of achieving a balanced budget thereafter. The bill was introduced on January 7, 2026, by Rep. Huizenga (R-MI-4) with 18 cosponsors and referred to three committees: Budget, Ways and Means, and Rules. An identical companion bill (SRES654) exists in the Senate. The bill status is 'Referred to committee — early stage', meaning no markup, no floor vote, no passage. As a non-binding sense-of-Congress resolution, it does not authorize or appropriate any funding ($0 in the funding amount). The money trail is entirely about signaling, not direct spending. If this resolution gains momentum and is followed by binding legislation (e.g., a budget reconciliation bill with spending cuts), the most exposed sectors are Defense and Healthcare. Defense discretionary spending (~$850B) and healthcare mandatory spending (Medicare ~$900B, Medicaid ~$600B) are the largest non-Social Security budget items. Any deficit reduction effort targeting 3% of GDP — requiring roughly $600-800B in annual cuts from CBO's FY2030 baseline of ~$2T deficits — would need to address both. Structural winners and losers: The losers are defense prime contractors (LMT, RTX, GD, BA) heavily reliant on government procurement, and healthcare payers (UNH, CVS) exposed to Medicare Advantage reimbursement. The resolution itself does not change any company's revenue today. The Presidential Actions on April 20, 2026 — a Defense Production Act determination for domestic petroleum and a memo reducing regulatory burden for Air Force jet training — are not directly relevant to this budget resolution. They reflect separate executive branch priorities in energy independence and defense operations. Real market data shows defense stocks already pricing in significant headwinds: LMT at $512.29, down -16.81% in 30 days; RTX at $175.68, down -7.4% in 30 days; GD at $313.68, down -9.54% in 30 days. BA is an outlier with a +21.1% 30-day gain to $230.72, reflecting commercial aerospace recovery momentum overwhelming defense concerns. Healthcare names show the opposite trend: UNH up +41.6% in 30 days to $366.77, CVS up +15.55% to $80.98 — indicating the market is NOT pricing in Medicare risk from this resolution yet. The divergence between defense (pricing in risk) and healthcare (pricing in none) is the key market signal. Timeline: The bill is at early stage with three referrals. The next steps are committee hearings (likely in Budget Committee), potential markup, and House floor vote. Given the 18 cosponsors and bipartisan nature of deficit concern, this resolution has a reasonable chance of House passage in 2026. However, even passage of a non-binding resolution does nothing directly — it merely creates political cover for future binding legislation in a potential 2027 budget process. The real market event would be a subsequent binding deficit reduction bill, not this resolution.